Purine and Pyrimidine (P2) Receptors as Drug Targets

ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTPurine and Pyrimidine (P2) Receptors as Drug TargetsKenneth A. Jacobson, Michael F. Jarvis, and Michael WilliamsView Author Information Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064, and Department of Molecular Pharmacology and Biological Chemistry, Northwestern University School of Medicine, Chicago, Illinois 60611 Cite this: J. Med. Chem. 2002, 45, 19, 4057–4093Publication Date (Web):August 20, 2002Publication History Received30 January 2002Published online20 August 2002Published inissue 1 September 2002https://pubs.acs.org/doi/10.1021/jm020046yhttps://doi.org/10.1021/jm020046yreview-articleACS PublicationsCopyright © 2002 American Chemical SocietyRequest reuse permissionsArticle Views2653Altmetric-Citations280LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstract